Oncology Biosimilars Market Size, Share & Trend | Industry Analysis Report, 2025

Oncology Biosimilars Market

Oncology Biosimilars Market Segmentation by Drug Class - GCSF, Monoclonal Antibodies, and Hematopoietic Agents; Disease Indication - Breast Cancer, Non-small Cell Lung Cancer, Colorectal Cancer, Neutropenia, and Blood Cancer (Leukemia and Non-Hodgkin Lymphoma); and Distribution Channel Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Forecast 2017 - 2025

Š2019 Transparency Market Research, All Rights Reserved

Table of Content Sr. No.

Content

Chapter 1

Preface

Chapter 2

Assumptions and Research Methodology

Chapter 3

Executive Summary: Global Oncology Biosimilars Market

Chapter 4

Market Overview

Chapter 5

Porter’s Five Force Analysis

Chapter 6

Market Dynamics

Chapter 7

Global Oncology Biosimilars Market Analysis and Forecasts, By Drug Class

Chapter 8

Global Oncology Biosimilars Market Analysis and Forecasts, By Disease Indication

Chapter 9

Global Oncology Biosimilars Market Analysis and Forecasts, By Distribution Channel

Chapter 10

Global Oncology Biosimilars Market Analysis and Forecasts, By Region

Chapter 11

North America Oncology Biosimilars Market Analysis and Forecast

Chapter 12

Europe Oncology Biosimilars Market Analysis and Forecast

Chapter 13

Asia Pacific Oncology Biosimilars Market Analysis and Forecast

Chapter 14

Rest of the World Oncology Biosimilars Market Analysis and Forecast

Chapter 15

Competition Landscape Š2019 Transparency Market Research, All Rights Reserved

Empty Capsules Market - Snapshot

The global oncology biosimilars market is predicted to benefit immensely with the rising demand for affordable therapies for cancer.

Pharmaceutical companies worldwide are hard-focused on developing biosimilars and generic medicines to combat cancer at all stages and also for the treatment of the disease.

Oncology biosimilars are similar versions of oncology biologics that are manufactured by different companies and have been officially approved for cancer treatment.

Š2019 Transparency Market Research, All Rights Reserved

Report Highlights The global oncology biosimilars market to expand at an outstanding 27.5% CAGR between 2017 and 2025, for the market to become worth US$17,478.2 mn by the end of 2025.

The report studies the global oncology biosimilars market based on a few parameters.

The segments into which the oncology biosimilars market is divided depending upon drug class are G-CSF, monoclonal antibody, and hematopoietic agents.

Request For Sample

Š2019 Transparency Market Research, All Rights Reserved

Continue..

Rising Initiatives to Meet Up Demand for Inexpensive Cancer Therapies to Drive Growth Efforts of Key Players to Widen Their Offerings and Patent Expiration to Boost Growth Leading companies in the global oncology biosimilars market that are profiled in this report are Celltrion Inc., Biocon, Dr. Reddy’s Laboratories Ltd., STADA Arzneimittel AG. Request For Brochure

Š2019 Transparency Market Research, All Rights Reserved

Contact

To know more about us, please visit our website:

www.transparencymarketresearch.com For sales queries or new topics email us on:

sales@transparencymarketresearch.com

Thank You

Š2019 Transparency Market Research, All Rights Reserved